A novel model to study mechanisms of cholestasis in human cholangiocytes reveals a role for the SIPR2 pathway.
Journal Information
Full Title: Hepatol Commun
Abbreviation: Hepatol Commun
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"CONFLICTS OF INTEREST Binita M. Kamath: Mirum (Consultant and Unrestricted educational grant), Albireo (Consultant and Unrestricted educational grant), Audentes (Consultant). Saul J. Karpen: Consultant for Albireo, Mirum, HemoShear, and Intercept. Michael Trauner: research grants from Albireo, Alnylam, Cymabay, Falk, Gilead, Intercept, MSD, Takeda, and Ultragenyx and travel grants from Abbvie, Falk, Gilead Intercept, and Jannsen. He further has advised for Abbvie, Albireo, BiomX, Boehringer Ingelheim, Falk Pharma GmbH, Genfit, Gilead, Hightide, Intercept, Janssen, MSD, Novartis, Phenex, Pliant, Regulus, Siemens, and Shire and has served as speaker for Albireo, BMS, Falk, Gilead, Intercept, Madrigal, and MSD. He is a coinventor of patents for the medical use of norUDCA (norursodeoxycholic acid/norucholic acid) filed by the Medical Universities of Graz and Vienna. The remaining authors have no conflicts to report."
"FUNDING INFORMATION This study was supported by CIHR project grant #175211."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025